News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MediGene AG (DX:MDG) Halts Trials In Vaccine Partnered With Aventis S.A. (AVE)


10/19/2005 5:11:19 PM

German biotechnology company MediGene AG (MDG.XE) has halted trials in an early-stage vaccine being tested to treat malignant melanoma, one of four products in its portfolio.

Read at Dow Jones

comments powered by Disqus
Dow Jones
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES